Singapore markets closed

Satellos Bioscience Inc. (0ITA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2780+0.0080 (+2.96%)
At close: 08:00AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Cost of revenue
206.937
-
-
119.919
48.161
Gross profit
-206.937
-
-
-119.919
-48.161
Operating expenses
Research development
2,567
8,817
3,734
2,004
892.781
Selling general and administrative
4,548
6,059
3,960
1,445
182.363
Total operating expenses
7,504
15,463
8,428
4,701
1,427
Operating income or loss
-7,711
-15,463
-8,428
-4,701
-1,475
Interest expense
177
177
0
985.332
23.049
Total other income/expenses net
-196.078
-1,582
-2,952
-9,827
-85.24
Income before tax
-8,778
-15,889
-11,317
-15,506
-1,579
Income tax expense
0
0
5
0
-
Income from continuing operations
-8,778
-15,889
-11,322
-15,506
-1,579
Net income
-8,778
-15,889
-11,322
-15,506
-1,579
Net income available to common shareholders
-8,778
-15,889
-11,322
-15,506
-1,579
Basic EPS
-0.25
-0.18
-0.32
-0.64
-0.05
Diluted EPS
-0.25
-0.18
-0.32
-0.64
-0.05
Basic average shares
68,656
86,405
35,680
24,076
32,867
Diluted average shares
68,656
86,405
35,680
24,076
32,867